Survival of patients with slow gonorrhea and patients with slow granulomas is related to the stage of the disease, the effectiveness of treatment, and the patient’s physical fitness. 1. Although the development of slow gonorrhea is slow, it is difficult to cure. According to Binet staging, it can be divided into stage A, B and C. Low-risk patients or patients with Binet stage A have a long survival period, and those with stable conditions can be observed regularly. The median survival of slow gonorrhea can be up to 10 years, and there are also patients who survive up to 10 years or more. Drugs include nitrogen mustard phenylbutyrate and ibrutinib. 2. Clinically, “5-year survival rate” is often used to assess the survival of tumor patients. Chronic granules can be divided into chronic stage, accelerated stage and acute stage, the 5-year overall survival rate and progression-free survival rate of chronic stage reaches 90% and 93% respectively, but the survival of patients in accelerated stage and acute stage is shorter, and their lives are often jeopardized by various complications within 3~6 months. In general, the earlier the disease is detected, diagnosed and treated, the less the disease affects the life expectancy. It is recommended that patients undergo regular treatment as early as possible and undergo regular review to prolong the survival time and improve the quality of life.